US Stock MarketDetailed Quotes
EYEN Eyenovia
- 0.830
- +0.045+5.68%
Close Aug 16 16:00 ET
- 0.850
- +0.020+2.41%
Post 19:59 ET
53.17MMarket Cap-1064P/E (TTM)
0.940High0.790Low1.73MVolume0.790Open0.785Pre Close1.46MTurnover3.72%Turnover RatioLossP/E (Static)64.06MShares2.57052wk High-22.43P/B38.53MFloat Cap0.50152wk Low--Dividend TTM46.42MShs Float10.740Historical High--Div YieldTTM19.07%Amplitude0.501Historical Low0.844Avg Price1Lot Size
Eyenovia Stock Forum
Sign in to post a comment
$Eyenovia (EYEN.US)$ Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the Treatment of Acute Dry Eye Disease in United States
2
1
$Eyenovia (EYEN.US)$
why bull is the best you should choose? because it has great opportunities in it
Insiders and Vanguard got call 10 to 15 M
2 fda sell start revenue will go up
1 fda result will come in Q4 2024
2 partnerships with huge companies
earnings result will coming in August.
why bull is the best you should choose? because it has great opportunities in it
Insiders and Vanguard got call 10 to 15 M
2 fda sell start revenue will go up
1 fda result will come in Q4 2024
2 partnerships with huge companies
earnings result will coming in August.
1
1
So ive been asked by quite a few people that are newer traders! And because of being where we all have been. They are learning charts and where to enter and exit on momentum / day trades. But having a bit of trouble. Again as we all did and at times still do. Most know that because i cant know others risk tolerance. Or the type of trade they are doing? That i do not give buy / sell advice. But i was asked could i give some swing trade ideas, so they could have a chance to ...
34
7
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
but you have these many holdings?$Eyenovia (EYEN.US)$ Eyenovia & Sgn Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease
2
$Eyenovia (EYEN.US)$ This company has 2 multi billion FDA products ready to be a complete before and after surgery treatment with a market of 2 billion
And 2 multi billion on phase 3 to treat blindness in children and dry eyes that has market about 15 to 20 billion worldwide
Some other companies has no FDA and worth billions but our company has 2 fda and still under 100 million
This is a keeper
And 2 multi billion on phase 3 to treat blindness in children and dry eyes that has market about 15 to 20 billion worldwide
Some other companies has no FDA and worth billions but our company has 2 fda and still under 100 million
This is a keeper
4
1
$Eyenovia (EYEN.US)$ up and up only with good news on the way
They got a partnership 2 days ago
They got Vanguard support
Launch day near in August for eyedrop
Earning call in August
3rd FDA result is coming in October 2024
No dilution because Vanguard and partnership will support financially for eyen
After that, the revenue from 2 fda forecasts
Eyen financial free
what do you want?
They got a partnership 2 days ago
They got Vanguard support
Launch day near in August for eyedrop
Earning call in August
3rd FDA result is coming in October 2024
No dilution because Vanguard and partnership will support financially for eyen
After that, the revenue from 2 fda forecasts
Eyen financial free
what do you want?
3
$Eyenovia (EYEN.US)$ Imagine after launch of eyedrop in August the revenue forecast 😳
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent and 30 to 50 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
1,800,000,000×30% =540,000,000 M per year
1,800,000,000×50% =900,000,000 M per year
This only 2 FDA appro...
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent and 30 to 50 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
1,800,000,000×30% =540,000,000 M per year
1,800,000,000×50% =900,000,000 M per year
This only 2 FDA appro...
+6
4
$Eyenovia (EYEN.US)$ Market Value are :
(Mydcombi)
1st FDA Market Value: 500M
(after surgery eyedrop for pain)
2nd FDA Market Value: 1.3B
(MicroPine)
3rd FDA Market Value: 1.8B
(Dry eyes)
4th FDA Market Value: 6B to 8B
................................
(Mydcombi)
1st FDA Market Value: 500M
(after surgery eyedrop for pain)
2nd FDA Market Value: 1.3B
(MicroPine)
3rd FDA Market Value: 1.8B
(Dry eyes)
4th FDA Market Value: 6B to 8B
................................
3
2
$Eyenovia (EYEN.US)$ Eyen signed a partnership to make a new drug to treat the dry eyes and enter market value 6 to 8 billion.
3
$Eyenovia (EYEN.US)$ Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease! Plan to meet with FDA on plan proposal
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Skrb : Hmm, cup and handle formation